Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis

Tracey M. Farragher, Mark Lunt, Bo Fu, Diane Bunn, Deborah P M Symmons

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis'. Together they form a unique fingerprint.

Immunology and Microbiology